Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  amonafide dihydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 45 for your search:
Start Over
Study of Individualized Amonafide to Treat Prostate Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 0001A2-200-US, NCT00087854
Phase II Chemotherapy with Amonafide for Patients with Stage III or IV non-Small Cell Lung Cancer (Summary Last Modified 05/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-8739, NCI-T87-0098C, T87-0098
Phase II Chemotherapy with Intravenous Amonafide in Patients with Extensive Small Cell Lung Cancer (Summary Last Modified 10/87)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-NCIC-IND42, NCI-T87-0137O, T87-0137, IND42
Phase II Chemotherapy with Amonafide in Patients with Unresectable or Metastatic Pancreatic Cancer (Summary Last Modified 02/89)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-5019, NCI-T87-0149O, T87-0149
Phase II Chemotherapy with Amonafide in Patients with Renal Cell Carcinoma (Summary Last Modified 04/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8716
Phase II Chemotherapy with Amonafide in Patients with Adenocarcinoma of the Prostate
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8722
Phase II Chemotherapy with Amonafide in Patients with Colorectal Carcinoma (Summary Last Modified 12/87)
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8714
Phase II Chemotherapy with Amonafide in Patients with Pancreatic Adenocarcinoma (Summary Last Modified 02/89)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8720
Phase II Chemotherapy with Amonafide in Patients with Advanced Hormone-Resistant Cancer of the Prostate (Summary Last Modified 02/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ICC-87U2, NCI-T87-0152D, T87-0152
Phase II Chemotherapy with Amonafide in Patients with Carcinoma of the Esophagus (Summary Last Modified 01/91)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8730
Phase II Chemotherapy with Amonafide in Patients with Endometrial Carcinoma (Summary Last Modified 04/89)
Phase: Phase II
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: SWOG-8732
Phase II Chemotherapy with Amonafide in Patients with Advanced Sarcomas (Summary Last Modified 04/88)
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8715
Phase II Chemotherapy with Amonafide in Patients with Refractory or Relapsing Multiple Myeloma (Summary Last Modified 06/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: SWOG-8726
Phase II Chemotherapy with Amonafide in Patients with Disseminated Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8723
Phase II Chemotherapy with Amonafide in Patients with Advanced Adenocarcinoma of the Stomach (Summary Last Modified 02/89)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ICC-88I1, NCI-T88-0040D, T88-0040
Phase II Master Protocol for Advanced, Recurrent Gynecologic Malignancies: Amonafide (Summary Last Modified 07/1999)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-26DD
Phase II Chemotherapy with BIDA or VM-26 in Patients with Metastatic non-Small Cell Bronchogenic Carcinoma (Summary Last Modified 07/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-2588
Phase II Study of Amonafide in Patients with Metaststic or Recurrent Colorectal Cancer (Summary Last Modified 10/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: FCCC-87898, NCI-T87-0198D, T87-0198
Phase II Chemotherapy with Intravenous Amonafide in Patients with Advanced Bladder Cancer (Summary Last Modified 11/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: OSU-88HO063, NCI-T88-0093D, T88-0093
Phase II Chemotherapy with Amonafide in Patients with Advanced Transitional Cell Carcinoma of the Urothelium (Summary Last Modified 08/89)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: FCCC-87897, NCI-T87-0197D, T87-0197
Phase II Chemotherapy with Amonafide in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 12/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: ICC-88N2, NCI-T88-0067D, T88-0067
Start Over